Di Donato Brian 4
4 · ACHILLION PHARMACEUTICALS INC · Filed Feb 11, 2019
Insider Transaction Report
Form 4
Di Donato Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to buy)
2019-02-11+500,000→ 500,000 totalExercise: $2.29Exp: 2029-02-11→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]This option vests as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.